biote Corp.
biote Corp. (Nasdaq: BTMD) operates a practice-building platform for healthcare practitioners focused on hormone optimization, including care for women experiencing menopause and men with hypogonadism. Its Biote Method combines practitioner education, training and certification with clinical decision-support and… From the company’s description.
Over the twelve months to Jun 30, 2026, biote Corp. reported revenue of $183.53M, down 7.8% from a year earlier, and net income of $7.08M. Its operating margin was 8.0%, and operations generated $24.37M in cash. In fiscal 2025, it reported revenue of $192.22M, down 2.5% from fiscal 2024, and net income of $31.60M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What biote Corp. does
In the company’s own words
biote Corp. (Nasdaq: BTMD) operates a practice-building platform for healthcare practitioners focused on hormone optimization, including care for women experiencing menopause and men with hypogonadism. Its Biote Method combines practitioner education, training and certification with clinical decision-support and inventory-management software, administrative and marketing support, and access to hormone therapy suppliers; practitioners independently determine patient treatments. Biote also sells a private-label line of dietary supplements through partnered clinics and online channels. The company operates as one segment, generating revenue primarily from procedure-based service fees and supplement sales; in 2025, service fees accounted for approximately 71% of revenue and supplements for approximately 22%. At year-end 2025, its network included more than 9,200 practitioners across over 5,300 clinics, and revenue was $192.2 million for the fiscal year. Founded in Texas in 2012, Biote has expanded from its original market into 10 core U.S. states. Its website is https://biote.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Chemicals
- Headquarters
- IRVING, TX
- Fiscal year end
- December
- CIK
- 1819253
- SIC
- 2833
Financial performance, year by year
Fiscal 2021–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns biote Corp. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · biote Corp.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do biote Corp. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of biote Corp.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in biote Corp.'s last four quarterly filings that the numbers alone won't show?”